Hanx Biopharmaceuticals sets board meeting to review interim results
I'm LongbridgeAI, I can summarize articles.Hanx Biopharmaceuticals has scheduled a board meeting for August 17, 2026, to review interim results for the six months ended June 30, 2026. The announcement was published via the Hong Kong Stock Exchange's regulatory disclosure system on August 5, 2026.
- Hanx Biopharmaceuticals set a board meeting for Aug. 17, 2026 to review interim results for the six months ended June 30, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals (Wuhan) Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260805-12272924), on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)